MANUEL MODIANO, M.D.
Osteopathic Medicine at Saint Marys Rd, Tucson, AZ
License number
Arizona 17060
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
1620 W Saint Marys Rd, Tucson, AZ 85745
Phone
(520) 624-7445
(520) 623-6145 (Fax)
(520) 519-7775
(520) 519-7760 (Fax)
(520) 623-6145 (Fax)
(520) 519-7775
(520) 519-7760 (Fax)
Organization information
See more information about MANUEL MODIANO at bizstanding.comManuel Modiano MD
1620 W Saint Marys Rd, Tucson, AZ 85745
Industry:
Hematologists, Oncology
Site:
Phone:
(520) 791-7996 (Phone)
Description:
There are 4 doctors at this site. Surgery is not performed at this site.
Manuel R. Modiano
Professional information
Dr. Manuel Modiano, Tucson AZ - MD (Doctor of Medicine)
Specialties:
Oncology, Hematology
Address:
St. Mary's
1620 W Saint Marys Rd, Tucson 85745
(520) 624-7445 (Phone), (520) 623-6145 (Fax)
1620 W Saint Marys Rd, Tucson 85745
(520) 624-7445 (Phone), (520) 623-6145 (Fax)
Procedures:
Bone Marrow Aspiration, Bone Marrow Biopsy, Breast Cancer, Breast Cancer Treatment, Cancer, Chemotherapeutic Agents, Chemotherapy, Clinical Trials, Medical Oncology
Conditions:
Anemia, Blood Diseases & Disorders, Blood Disorders, Breast Cancer, Cancer, Cancer Care, Cancer Consultation, Cancer Treatment, Cancer Treatment (Oncology) Complications, Colon Cancer, Colorectal (Colon) Cancer, Hematology, Lung Cancer, Lymphoma, Non-Hodgkin's Lymphoma, Oncology, Prostate Cancer
Languages:
English, Spanish
Hospitals:
St. Mary's
1620 W Saint Marys Rd, Tucson 85745
Carondelet St. Mary's Hospital
1601 West Saint Marys Rd, Tucson 85745
Mount Graham Regional Medical Center
1600 South 20Th Ave, Safford 85546
1620 W Saint Marys Rd, Tucson 85745
Carondelet St. Mary's Hospital
1601 West Saint Marys Rd, Tucson 85745
Mount Graham Regional Medical Center
1600 South 20Th Ave, Safford 85546
Education:
Medical School
Universidad Nacional Autonoma De Mexico
Graduated: 1982
Sinai Samaritan Medical Center
Graduated: 1984
Sinai Samaritan Med Center
Graduated: 1986
Arizona Cancer Center-Univ Of Arizona
Graduated: 1988
Universidad Nacional Autonoma De Mexico
Graduated: 1982
Sinai Samaritan Medical Center
Graduated: 1984
Sinai Samaritan Med Center
Graduated: 1986
Arizona Cancer Center-Univ Of Arizona
Graduated: 1988
Manuel R Modiano, Tucson AZ
Specialties:
Internal Medicine, Hematology & Oncology, Hematology, Medical Oncology, Gynecologic Oncology, Hematology
Work:
Arizona Onc Servs.
1620 W Saint Marys Rd, Tucson, AZ 85745 Arizona Onc Servs.
2115 W 16Th St, Safford, AZ 85546
1620 W Saint Marys Rd, Tucson, AZ 85745 Arizona Onc Servs.
2115 W 16Th St, Safford, AZ 85546
Education:
Universidad Nacional Autonoma De Mexico, Df (1981)
Manuel R Modiano, Tucson AZ
Specialties:
Hematologist
Address:
1620 W Saint Marys Rd, Tucson, AZ 85745
1760 E River Rd, Tucson, AZ 85718
1760 E River Rd, Tucson, AZ 85718
Biologically Active Taxane Analogs And Methods Of Treatment By Oral Administration
US Patent:
8273789, Sep 25, 2012
Filed:
Sep 1, 2010
Appl. No.:
12/873477
Inventors:
James D. McChesney - Etta MS, US
Gilles Tapolsky - Boulder CO, US
David L. Emerson - Longmont CO, US
John Marshall - Washington DC, US
Tauseef Ahmed - Hawthorne NY, US
Allen Cohn - Denver CO, US
Michael Kurman - Upper Saddle River NJ, US
Manuel Modiano - Tucson AZ, US
Gilles Tapolsky - Boulder CO, US
David L. Emerson - Longmont CO, US
John Marshall - Washington DC, US
Tauseef Ahmed - Hawthorne NY, US
Allen Cohn - Denver CO, US
Michael Kurman - Upper Saddle River NJ, US
Manuel Modiano - Tucson AZ, US
Assignee:
Tapestry Pharmaceuticals, Inc. - Boulder CO
International Classification:
A61K 31/35, A61K 31/335, C07D 309/00, C07D 407/00
US Classification:
514453, 514357, 514449, 549510, 549511, 549357, 549358
Abstract:
The present invention relates to a novel chemical compound of formula S-(1):.
Taxane Analogs For The Treatment Of Brain Cancer
US Patent:
8409574, Apr 2, 2013
Filed:
Aug 20, 2010
Appl. No.:
12/859990
Inventors:
James D. McChesney - Etta MS, US
Gilles Tapolsky - Boulder CO, US
David E. Emerson - Longmont CO, US
John Marshall - Washington DC, US
Tauseef Ahmed - Briarcliff Manor NY, US
Allen Cohn - Englewood CO, US
Michael Kurman - Upper Saddle River NJ, US
Manuel Modiano - Tucson AZ, US
Gilles Tapolsky - Boulder CO, US
David E. Emerson - Longmont CO, US
John Marshall - Washington DC, US
Tauseef Ahmed - Briarcliff Manor NY, US
Allen Cohn - Englewood CO, US
Michael Kurman - Upper Saddle River NJ, US
Manuel Modiano - Tucson AZ, US
International Classification:
A61K 39/00, A61K 31/415, A61K 31/335, A01N 43/52, A01N 43/32, C07D 309/00
US Classification:
4241331, 514393, 514452, 549358
Abstract:
Provided herein are compounds and methods for the treatment of brain cancer in a mammal, wherein the method comprises the administration to the mammal a compound that stabilizes tubulin dimers or microtubles at G2-M interface during mitosis but is not a substrate for MDR protein. In particular, the present application relates to the use of an orally effective abeo-taxane, alone or in combination with temozolomide or bevacizumab, for the treatment of brain cancer.
Biologically Active Taxane Analogs And Methods Of Treatment By Oral Administration
US Patent:
8552056, Oct 8, 2013
Filed:
Sep 15, 2012
Appl. No.:
13/620852
Inventors:
James D. McChesney - Etta MS, US
Gilles Tapolsky - Boulder CO, US
David E. Emerson - Longmont CO, US
John Marshall - Washington DC, US
Tauseef Ahmed - Hawthorne NY, US
Allen Cohn - Denver CO, US
Michael Kurman - Upper Saddle River NJ, US
Manuel Modiano - Tucson AZ, US
Gilles Tapolsky - Boulder CO, US
David E. Emerson - Longmont CO, US
John Marshall - Washington DC, US
Tauseef Ahmed - Hawthorne NY, US
Allen Cohn - Denver CO, US
Michael Kurman - Upper Saddle River NJ, US
Manuel Modiano - Tucson AZ, US
Assignee:
Tapestry Pharmaceuticals, Inc. - Boulder CO
International Classification:
A61K 31/335, A61K 31/44, C07D 407/00, C07D 309/00
US Classification:
514449, 514357, 549510, 549511, 549357, 549358
Abstract:
The present invention relates to a novel chemical compound of formula S-(1):.
Taxane Analogs For The Treatment Of Brain Cancer
US Patent:
2013025, Sep 26, 2013
Filed:
Mar 5, 2013
Appl. No.:
13/785753
Inventors:
Gilles Tapolsky - Louisville KY, US
David E. Emerson - Longmont CO, US
John Marshall - Washington DC, US
Tauseef Ahmed - Briarcliff Manor NY, US
Allen Cohn - Englewood CO, US
Michael Kurman - Upper Saddle River NJ, US
Manuel Modiano - Tucson AZ, US
David E. Emerson - Longmont CO, US
John Marshall - Washington DC, US
Tauseef Ahmed - Briarcliff Manor NY, US
Allen Cohn - Englewood CO, US
Michael Kurman - Upper Saddle River NJ, US
Manuel Modiano - Tucson AZ, US
International Classification:
A61K 31/357
US Classification:
514452, 549358
Abstract:
Provided herein are compounds and methods for the treatment of brain cancer in a mammal, wherein the method comprises the administration to the mammal a compound that stabilizes tubulin dimers or microtubles at G2-M interface during mitosis but is not a substrate for MDR protein. In particular, the present application relates to the use of an orally effective abeo-taxane, alone or in combination with temozolomide or bevacizumab, for the treatment of brain cancer.
Biologically Active Taxane Analogs And Methods Of Treatment By Oral Administration
US Patent:
2014002, Jan 23, 2014
Filed:
Jul 25, 2013
Appl. No.:
13/950316
Inventors:
James D. McChesney - Etta MS, US
Gilles H. Tapolsky - Louisville KY, US
David Lloyd Emerson - Longmont CO, US
John Marshall - Washington DC, US
Tauseef Ahmed - New York NY, US
Allen Cohn - Eaglewood CO, US
Michael Kurman - Upper Saddle River NJ, US
Manuel R. Modiano - Tucson AZ, US
Gilles H. Tapolsky - Louisville KY, US
David Lloyd Emerson - Longmont CO, US
John Marshall - Washington DC, US
Tauseef Ahmed - New York NY, US
Allen Cohn - Eaglewood CO, US
Michael Kurman - Upper Saddle River NJ, US
Manuel R. Modiano - Tucson AZ, US
International Classification:
C07D 493/06, A61K 39/395, A61K 31/495, A61K 31/357, A61K 45/06
US Classification:
424450, 514452, 514393, 4241331
Abstract:
The present invention relates to a novel chemical compound for use in the treatment of cancer, to compositions containing said compound, methods of manufacture and combinations with other therapeutic agents.